144 related articles for article (PubMed ID: 36866704)
1. Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212.
Badrick T
Clin Chem Lab Med; 2023 Jul; 61(8):e135-e136. PubMed ID: 36866704
[No Abstract] [Full Text] [Related]
2. Response to Tony Badrick regarding "Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205-212 by".
Dimech WJ; Vincini GA; Plebani M; Lippi G; Nichols JH; Sonntag O
Clin Chem Lab Med; 2023 Jul; 61(8):e137-e139. PubMed ID: 36872632
[No Abstract] [Full Text] [Related]
3. Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970-8.
Badrick T; Parvin C
Clin Chem Lab Med; 2019 Apr; 57(5):e71-e72. PubMed ID: 30904900
[No Abstract] [Full Text] [Related]
4. Six Sigma driven QC in antibody testing for infectious diseases.
Khelil MM
Clin Chem Lab Med; 2024 Jan; 62(2):e40-e43. PubMed ID: 37559170
[No Abstract] [Full Text] [Related]
5. Time to address quality control processes applied to antibody testing for infectious diseases.
Dimech WJ; Vincini GA; Plebani M; Lippi G; Nichols JH; Sonntag O
Clin Chem Lab Med; 2023 Jan; 61(2):205-212. PubMed ID: 36345644
[TBL] [Abstract][Full Text] [Related]
6. Determination of quality control limits for serological infectious disease testing using historical data.
Dimech W; Vincini G; Karakaltsas M
Clin Chem Lab Med; 2015 Feb; 53(2):329-36. PubMed ID: 25153420
[TBL] [Abstract][Full Text] [Related]
7. Counterpoint to the Letter to the Editor by Badrick and Parvin in regard to Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing.
Dimech W; Vincini G; Karakaltas M
Clin Chem Lab Med; 2019 Apr; 57(5):e73-e74. PubMed ID: 30710479
[No Abstract] [Full Text] [Related]
8. To the editor: in reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522-532.
Robson E; Mead G; Bradwell A
Clin Chem Lab Med; 2007; 45(2):264-5; author reply 266-7. PubMed ID: 17311521
[No Abstract] [Full Text] [Related]
9. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing.
Dimech W; Karakaltsas M; Vincini GA
Clin Chem Lab Med; 2018 Oct; 56(11):1970-1978. PubMed ID: 29794255
[TBL] [Abstract][Full Text] [Related]
10. Nucleic acid analysis by sandwich hybridization.
Nicholls PJ; Malcolm AD
J Clin Lab Anal; 1989; 3(2):122-35. PubMed ID: 2471820
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.
Santambrogio L; Rammensee HG
Immunogenetics; 2019 Mar; 71(3):203-216. PubMed ID: 30343358
[TBL] [Abstract][Full Text] [Related]
12. Reply to the article entitled "Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D" by Farrell et al., Clin Chem Lab Med 2014;52:1579-87.
Donnelly J; Freeman J; Wilson K; Shalhoub V; Sibley P
Clin Chem Lab Med; 2015 Apr; 53(5):e129-30. PubMed ID: 25332295
[No Abstract] [Full Text] [Related]
13. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor relating to Clin Chem Lab Med 2018;56(7):1090-1099.
Infantino M; Grossi V; Benucci M; Manfredi M
Clin Chem Lab Med; 2019 Mar; 57(4):e45-e46. PubMed ID: 30138111
[No Abstract] [Full Text] [Related]
15. Are enzyme-linked immunosorbent assay and immunoblot assay independent in immunodiagnosis of infectious diseases?
Katti MK
Clin Infect Dis; 2001 Apr; 32(7):1114. PubMed ID: 11264047
[No Abstract] [Full Text] [Related]
16. Letter to the Editor relating to Clin Chem Lab Med 2022;60(9):1365-72.
Sun X; Wang Q; Shi Q
Clin Chem Lab Med; 2022 Oct; 60(11):e243. PubMed ID: 36050862
[No Abstract] [Full Text] [Related]
17. Immunoserology of infectious diseases.
James K
Clin Microbiol Rev; 1990 Apr; 3(2):132-52. PubMed ID: 2187592
[TBL] [Abstract][Full Text] [Related]
18. Reply to the Letter of Sun et al. [1] relating to Clin Chem Lab Med 2022;60(9):1365-72.
Smith TP; Fahie-Wilson MN
Clin Chem Lab Med; 2022 Oct; 60(11):e244-e245. PubMed ID: 36052827
[No Abstract] [Full Text] [Related]
19. Letter to the Editor relative to Clin Chem Lab Med 2018;56(3):360-372.
Gay A
Clin Chem Lab Med; 2018 Oct; 56(11):251-252. PubMed ID: 29668442
[No Abstract] [Full Text] [Related]
20. Criticism to the article: "Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method". Authors: J.O Jeppsson et al. Clin Chem Lab Med 2007; 45(4):558-562.
Tagliaro F; Bortolotti F
Clin Chem Lab Med; 2008; 46(5):725-6; author reply 727-8. PubMed ID: 18839475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
